A detailed history of Raleigh Capital Management Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 84 shares of EW stock, worth $5,691. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84
Previous 128 34.38%
Holding current value
$5,691
Previous $11,000 54.55%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$59.7 - $93.78 $2,626 - $4,126
-44 Reduced 34.38%
84 $5,000
Q2 2024

Jul 31, 2024

BUY
$84.3 - $94.31 $1,517 - $1,697
18 Added 16.36%
128 $11,000
Q1 2024

May 13, 2024

BUY
$72.54 - $95.56 $5,803 - $7,644
80 Added 266.67%
110 $10,000
Q4 2023

Feb 21, 2024

BUY
$61.71 - $77.76 $1,851 - $2,332
30 New
30 $2,000
Q3 2022

Nov 09, 2022

SELL
$82.37 - $107.29 $3,624 - $4,720
-44 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$101.96 - $128.34 $4,486 - $5,646
44 New
44 $5,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Raleigh Capital Management Inc. Portfolio

Follow Raleigh Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raleigh Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raleigh Capital Management Inc. with notifications on news.